Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Fernando G . Cosio, M.D.

Back to Research Profile

  1. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG. Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-CD20 Monoclonal Antibodies. Am J Transplant 2009 Oct 21. [Epub ahead of print]
    View PubMed
  2. Grafft CA, Cornell LD, Gloor JM, Cosio FG, Gandhi MJ, Dean PG, Stegall MD, Amer H. Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant 2009 Oct 20. [Epub ahead of print]
    View PubMed
  3. Amer H, Cosio FG. Significance and Management of Proteinuria in Kidney Transplant Recipients. J Am Soc Nephrol 2009 Oct 09. [Epub ahead of print]
    View PubMed
  4. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant 2009 Aug; 9(8):1894-902.
    View PubMed
  5. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant 2009 Aug; 9(8):1894-902. Epub 2009 Jun 10.
    View PubMed
  6. Gaston RS, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Halloran PF, Hunsicker L, Rush D, Matas AJ. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009 Aug; 9(8):1811-5.
    View PubMed
  7. Zhang Y, Oetting WS, Harvey SB, Stone MD, Monkkonen T, Matas AJ, Cosio FG, Nelsestuen GL. Urinary peptide patterns in native kidneys and kidney allografts. Transplantation 2009 Jun 27; 87(12):1807-13.
    View PubMed
  8. Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant 2009 Jun; 9(6):1354-61. Epub 2009 May 13.
    View PubMed
  9. Hickson LTJ, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant 2009 Jun; 9(6):1354-61.
    View PubMed
  10. Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 2009 Apr 27; 87(8):1232-9.
    View PubMed
  11. Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol 2009 Apr; 4(4):853-9. Epub 2009 Apr 01.
    View PubMed
  12. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG. Identifying specific causes of kidney allograft loss. Am J Transplant 2009 Mar; 9(3):527-35. Epub 2008 Feb 03.
    View PubMed
  13. Czarnecki PG, Lager DJ, Leung N, Dispenzieri A, Cosio FG, Fervenza FC. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int 2009 Feb; 75(4):420-7. Epub 2008 Nov 26.
    View PubMed
  14. Soares SM, Fervenza FC, Lager DJ, Gertz MA, Cosio FG, Leung N. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis 2008 Dec; 52(6):1079-83. Epub 2008 Jul 23.
    View PubMed
  15. Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008 Nov 27; 86(10):1384-8.
    View PubMed
  16. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, Griffin MD, Jaffe AS. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant 2008 Nov; 8(11):2352-9. Epub 2008 Sep 10.
    View PubMed
  17. Issa N, Cosio FG, Gloor JM, Sethi S, Dean PG, Moore SB, DeGoey S, Stegall MD. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008 Sep 15; 86(5):681-5.
    View PubMed
  18. Gloor J, Cosio F, Lager DJ, Stegall MD. The spectrum of antibody-mediated renal allograft injury: implications for treatment. Am J Transplant 2008 Jul; 8(7):1367-73.
    View PubMed
  19. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant 2008 Jun; 8(6):1318-22. Epub 2008 Apr 29.
    View PubMed
  20. Dean PG, Grande JP, Sethi S, Park WD, Griffin MD, Cosio FG, Larson TS, Stegall MD. Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. Transplantation 2008 Apr 27; 85(8):1212-5.
    View PubMed
  21. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008 Apr; 8(4):753-60. Epub 2008 Feb 19.
    View PubMed
  22. Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008 Mar 15; 46(6):840-6.
    View PubMed
  23. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 2008 Mar; 8(3):593-9.
    View PubMed
  24. Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, Torres VE. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol 2008 Mar; 19(3):631-8. Epub 2008 Jan 16.
    View PubMed
  25. Cosio FG, Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant 2008 Mar; 8(3):492-6.
    View PubMed
  26. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 2008 Jan; 73(1):117-25. Epub 2007 Oct 17.
    View PubMed
  27. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, Stegall MD, Cosio FG. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007 Dec; 7(12):2748-56. Epub 2007 Oct 17.
    View PubMed
  28. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, Degoey S, Griffin MD, Larson TS, Cosio FG. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007 Sep; 7(9):2124-32. Epub 2007 Jul 03.
    View PubMed
  29. Park W, Griffin M, Grande JP, Cosio F, Stegall MD. Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation 2007 Jun 15; 83(11):1466-76.
    View PubMed
  30. Khamash HA, Wadei HM, Mahale AS, Larson TS, Stegall MD, Cosio FG, Griffin MD. Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int 2007 Jun; 71(12):1302-9. Epub 2007 Apr 04.
    View PubMed
  31. Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, Larson TS, Schwab TR, Stegall MD, Textor SC. Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol 2007 May; 18(5):1607-15.
    View PubMed
  32. Abbud M, Adams PL, Alberu J, Cardella C, Chapman J, Cochat P, Cosio F, Danovitch G, Davis C, Gaston RS, Humar A, Hunsicker LG, Josephson MA, Kasiske B, Kirste G, Leichtman A, Munn S, Obrador GT, Tibell A, Wadstrom J, Zeier M, Delmonico FL. A report of the Lisbon conference on the care of the kidney transplant recipient. Transplantation 2007 Apr 27; 83(8 Suppl S):S1-S22.
    View PubMed
  33. Gera M, Slezak JM, Rule AD, Larson TS, Stegall MD, Cosio FG. Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant 2007 Apr; 7(4):880-7.
    View PubMed
  34. Mengel M, Chapman JR, Cosio FG, Cavaille-Coll MW, Haller H, Halloran PF, Kirk AD, Mihatsch MJ, Nankivell BJ, Racusen LC, Roberts IS, Rush DN, Schwarz A, Seron D, Stegall MD, Colvin RB. Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant 2007 Mar; 7(3):512-7.
    View PubMed
  35. Cosio FG, Amer H, Grande JP, Larson TS, Stegall MD, Griffin MD. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation 2007 Feb 27; 83(4):411-6.
    View PubMed
  36. Innocenti GR, Wadei HM, Prieto M, Dean PG, Ramos EJ, Textor S, Khamash H, Larson TS, Cosio F, Kosberg K, Fix L, Bauer C, Stegall MD. Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation 2007 Jan 27; 83(2):144-9.
    View PubMed
  37. Rule AD, Rodeheffer RJ, Larson TS, Burnett JC Jr, Cosio FG, Turner ST, Jacobsen SJ. Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc 2006 Nov; 81(11):1427-34.
    View PubMed
  38. Rea DJ, Heimbach JK, Grande JP, Textor SC, Taler SJ, Prieto M, Larson TS, Cosio FG, Stegall MD. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006 Nov; 70(9):1636-41. Epub 2006 Sep 06.
    View PubMed
  39. Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, DeGoey SR, Lager DJ, Grande JP, Stegall MD. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 Aug; 6(8):1841-7. Epub 2006 Jun 19.
    View PubMed
  40. Myslak M, Amer H, Morales P, Fidler ME, Gloor JM, Larson TS, Stegall MD, Cosio FG. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant 2006 Jul; 6(7):1660-5.
    View PubMed
  41. Wadei HM, Rule AD, Lewin M, Mahale AS, Khamash HA, Schwab TR, Gloor JM, Textor SC, Fidler ME, Lager DJ, Larson TS, Stegall MD, Cosio FG, Griffin MD. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006 May; 6(5 Pt 1):1025-32.
    View PubMed
  42. Larson TS, Dean PG, Stegall MD, Griffin MD, Textor SC, Schwab TR, Gloor JM, Cosio FG, Lund WJ, Kremers WK, Nyberg SL, Ishitani MB, Prieto M, Velosa JA. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006 Mar; 6(3):514-22.
    View PubMed
  43. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005 Oct; 5(10):2464-72.
    View PubMed
  44. Leung N, Griffin MD, Dispenzieri A, Haugen EN, Gloor JM, Schwab TR, Textor SC, Lacy MQ, Litzow MR, Cosio FG, Larson TS, Gertz MA, Stegall MD. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant 2005 Jul; 5(7):1660-70.
    View PubMed
  45. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005 Jun; 67(6):2415-21.
    View PubMed
  46. Norby SM, Cosio FG. Thin basement membrane nephropathy associated with other glomerular diseases. Semin Nephrol 2005 May; 25(3):176-9.
    View PubMed
  47. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 2005 May; 5(5):1057-64.
    View PubMed
  48. Cosio FG, Grande JP, Larson TS, Gloor JM, Velosa JA, Textor SC, Griffin MD, Stegall MD. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005 May; 5(5):1130-6.
    View PubMed
  49. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 2004 Dec 21; 141(12):929-37.
    View PubMed
  50. de la Vega LSP, Torres A, Bohorquez HE, Heimbach JK, Gloor JM, Schwab TR, Taler SJ, Nyberg SL, Ishitani MB, Prieto M, Velosa JA, Larson TS, Stegall MD, Cosio FG, Textor SC, Griffin MD. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int 2004 Oct; 66(4):1654-61.
    View PubMed
  51. Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, Leichtman AB, Delmonico FL. Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report. Am J Kidney Dis 2004 Sep; 44(3):529-42.
    View PubMed
  52. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, Cosio F, Schwab T, Prieto M, Nyberg S, Ishitani M, Stegall M. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004 Jul 27; 78(2):276-82.
    View PubMed
  53. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004 Jan; 43(1):112-9.
    View PubMed
  54. Stegall MD, Larson TS, Prieto M, Gloor J, Textor S, Nyberg S, Sterioff S, Ishitani M, Griffin M, Kremers W, Lund W, Schwab T, Cosio F, Velosa J. Kidney transplantation without calcineurin inhibitors using sirolimus. Transplant Proc 2003 May; 35(3A Suppl S):125S-127S.
    View PubMed
  55. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002 Oct; 62(4):1440-6.
    View PubMed
  56. Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S. Patient survival after renal transplantation III: the effects of statins. Am J Kidney Dis 2002 Sep; 40(3):638-43.
    View PubMed
  57. Bostom AD, Brown RS Jr, Chavers BM, Coffman TM, Cosio FG, Culver K, Curtis JJ, Danovitch GM, Everson GT, First MR, Garvey C, Grimm R, Hertz MI, Hricik DE, Hunsicker LG, Ibrahim H, Kasiske BL, Kennedy M, Klag M, Knatterud ME, Kobashigawa J, Lake JR, Light Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group. Am J Transplant 2002 Jul; 2(6):491-500.
    View PubMed
  58. Stegall MD, Larson TS, Prieto M, Gloor J, Textor S, Nyberg S, Sterioff S, Ishitani M, Griffin M, Schwab T, Talor S, Cosio F, Kudva Y, Dicke-Henslin D, Kreps M, Fix L, Bauer C, Murphy M, Kosberg K, Tarara D, Velosa J. Living-donor kidney transplantation at Mayo Clinic--Rochester. Clin Transpl 2002; 155-61.
  59. Wilmer WA, Voroshilova O, Singh I, Middendorf DF, Cosio FG. Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis 2001 Apr; 37(4):797-806.
    View PubMed
  60. Cosio FG, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM, Mitchell L, Lemeshow S. Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. Kidney Int 2001 Mar; 59(3):1158-64.
    View PubMed
  61. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001 Feb; 59(2):732-7.
    View PubMed
  62. Saxena R, Frankel WL, Sedmak DD, Falkenhain ME, Cosio FG. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: successful treatment with plasmapheresis. Am J Kidney Dis 2000 Apr; 35(4):749-52.
    View PubMed
  63. Cosio FG. La supervivencia de enfermos con trasplantes renales. Revista de la Sociedad Espanola de Enfermeria Nefrologica 2000; 12:23-7.
  64. Pesavento TE, Henry ML, Falkenhain ME, Cosio FG, Bumgardner GL, Elkhammas EA, Pelletier RP, Ferguson RM. Obese living kidney donors: short-term results and possible implications. Transplantation 1999 Nov 27; 68(10):1491-6.
    View PubMed
  65. Cosio FG, Pelletier RP, Sedmak DD, Pesavento TE, Henry ML, Ferguson RM. Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology. Kidney Int 1999 Nov; 56(5):1912-9.
    View PubMed
  66. Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival. Am J Kidney Dis 1999 Oct; 34(4):731-8.
    View PubMed
  67. Cosio FG, Falkenhain ME, Pesavento TE, Yim S, Alamir A, Henry ML, Ferguson RM. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 1999 Aug; 13(4):336-41.
    View PubMed
  68. Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, Hebert LA. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999 Apr; 10(4):833-9.
    View PubMed
  69. Cosio FG, Pelletier RP, Sedmak DD, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Pathologic classification of chronic allograft nephropathy: pathogenic and prognostic implications. Transplantation 1999 Mar 15; 67(5):690-6.
    View PubMed
  70. Cosio FG, Pelletier RP, Sedmak DD. Predictive value of histopathology and function on outcome of renal allografts after acute rejection. Transplant Proc 1999 Feb-Mar; 31(1-2):261-3.
    View PubMed
  71. Hebert LA, Falkenhain ME, Nahman NS Jr, Cosio FG, O'Dorisio TM. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol 1999; 19(1):1-6.
    View PubMed
  72. Pelletier RP, Cosio F, Henry ML, Bumgardner GL, Davies EA, Elkhammas EA, Ferguson RM. Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time. Clin Transplant 1998 Dec; 12(6):543-52.
    View PubMed
  73. Cosio FG, Pesavento TE, Sedmak DD, Farhan N, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. Clinical implications of the diagnosis of renal allograft infarction by percutaneous biopsy. Transplantation 1998 Aug 27; 66(4):467-71.
    View PubMed
  74. Wilmer WA, Kaumaya PT, Ember JA, Cosio FG. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells. J Immunol 1998 Jun 1; 160(11):5646-52.
    View PubMed
  75. Wilmer WA, Cosio FG. DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int 1998 May; 53(5):1172-81.
    View PubMed
  76. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998 Mar; 53(3):767-72.
    View PubMed
  77. Cosio FG, Elkhammas EA, Henry ML, Pesavento TE, Sedmak DD, Pelletier RP, Bumgardner GL, Ferguson RM. Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients. Transplantation 1998 Jan 15; 65(1):93-9.
    View PubMed
  78. Dillon JJ, Sedmak DD, Cosio FG. Rapid-onset diabetic nephropathy in type II diabetes mellitus. Ren Fail 1997 Nov; 19(6):819-22.
    View PubMed
  79. Hebert LA, Birmingham DJ, Mahan JD, Cosio FG, Dillon JJ, Sedmak DD, Shen XP, McAllister C. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis 1997 Aug; 30(2):243-52.
    View PubMed
  80. Cosio FG, Pelletier RP, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997 Jun 15; 63(11):1611-5.
    View PubMed
  81. Cosio FG, Falkenhain ME, Pesavento TE, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Relationships between arterial hypertension and renal allograft survival in African-American patients. Am J Kidney Dis 1997 Mar; 29(3):419-27.
    View PubMed
  82. Cosio FG. Combined kidney and pancreas transplants versus kidneys alone. Audio Journal of Transplantation 1997; 2(1).
  83. Cosio FG, Qiu W, Henry ML, Falkenhain ME, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation 1996 Dec 15; 62(11):1571-6.
    View PubMed
  84. Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996 Nov; 28(5):752-8.
    View PubMed
  85. Cosio FG, Sedmak DD, Henry ML, Al Haddad C, Falkenhain ME, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996 Oct 27; 62(8):1054-9.
    View PubMed
  86. Falkenhain ME, Cosio FG, Sedmak DD. Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation 1996 Aug 15; 62(3):364-70.
    View PubMed
  87. Cosio FG, Hebert LA. [Complement in kidney diseases] [Spanish]. Rev Clin Esp 1996 Mar; 196 Spec No:36-43.
    View PubMed
  88. Cosio FG, Hernandez RA. Favorable prognostic significance of raised serum C3 concentration in patients with idiopathic focal glomerulosclerosis. Clin Nephrol 1996 Mar; 45(3):146-52.
    View PubMed
  89. Hebert LA, Betts JA, Sedmak DD, Cosio FG, Bay WH, Carlton S. Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules. Kidney Int 1996 Jan; 49(1):168-73.
    View PubMed
  90. Cosio FG, Wilmer WA. Effects of high glucose concentration on c-fos: role of protein kinase C. Kidney Int Suppl 1995 Sep; 51:S12-7.
    View PubMed
  91. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int 1995 Apr; 47(4):1136-41.
    View PubMed
  92. Cosio FG. Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 1995 Feb; 5(8):1600-9.
    View PubMed
  93. Cosio FG, Betts JA. Management of primary glomerulopathies. Conn's Current Therapy. Saunders. 1995.
  94. Cosio FG, Shibata T, Rovin BH, Birmingham DJ. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int 1994 Oct; 46(4):986-92.
    View PubMed
  95. Cosio FG, Falkenhain ME, Sedmak DD. Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 1994 Aug; 46(2):471-4.
    View PubMed
  96. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol 1994 Apr; 4(10):1786-91.
    View PubMed
  97. Hebert LA, Birmingham DJ, Mahan JD, Shen XP, McAllister C, Cosio FG, Dillon JJ. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int 1994 Feb; 45(2):493-9.
    View PubMed
  98. Hajinazarian M, Cosio FG, Nahman NS Jr, Mahan JD. Angiotensin-converting enzyme inhibition partially prevents diabetic organomegaly. Am J Kidney Dis 1994 Jan; 23(1):105-17.
    View PubMed
  99. Mahan JD, Hebert LA, McAllister C, Birmingham DJ, Shen XP, Cosio FG, Brandt J. Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int 1993 Oct; 44(4):716-25.
    View PubMed
  100. Cosio FG. Fibronectin metabolism by human mesangial cells: effects of collagens. Am J Physiol 1993 Jan; 264(1 Pt 2):F106-19.
    View PubMed
  101. Cosio FG, Orosz CG. Adhesion molecules and the kidney in health and disease. J Nephrol 1993; 6:22-32.
  102. Hebert LA, Cosio FG, Birmingham DJ. The role of the complement system in renal injury. Semin Nephrol 1992 Sep; 12(5):408-27.
    View PubMed
  103. Cosio FG. Cell-matrix adhesion receptors: relevance to glomerular pathology. Am J Kidney Dis 1992 Sep; 20(3):294-305.
    View PubMed
  104. Hebert LA, Birmingham DJ, Shen XP, Cosio FG. Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clinical Immunology & Immunopathology 1992 Mar; 62(3):301-6.
    View PubMed
  105. Nahman NS Jr, Leonhart KL, Cosio FG, Hebert CL. Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 1992 Feb; 41(2):396-402.
    View PubMed
  106. Shibata T, Cosio FG, Birmingham DJ. Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 1991 Dec 1; 147(11):3901-8.
    View PubMed
  107. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W. Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 1991 Dec; 40(6):1141-7.
    View PubMed
  108. Hebert LA, Cosio FG, Birmingham DJ, Mahan JD. Biologic significance of the erythrocyte complement receptor: a primate perquisite. Journal of Laboratory & Clinical Medicine 1991 Oct; 118(4):301-8.
    View PubMed
  109. Hebert LA, Cosio FG, Birmingham DJ, Mahan JD, Sharma HM, Smead WL, Goel R. Experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int 1991 Jan; 39(1):44-56.
    View PubMed
  110. Cosio FG, Shen XP, Birmingham DJ, Van Aman M, Hebert LA. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol 1990 Dec 15; 145(12):4198-206.
    View PubMed
  111. Cosio FG, Sedmak DD, Nahman NS Jr. Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int 1990 Nov; 38(5):886-95.
    View PubMed
  112. Birmingham DJ, Hebert LA, Cosio FG, VanAman ME. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. Journal of Laboratory & Clinical Medicine 1990 Aug; 116(2):242-52.
    View PubMed
  113. Cosio FG, Shen XP, Hebert LA. Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clinical Immunology & Immunopathology 1990 Jun; 55(3):337-54.
    View PubMed
  114. Cosio FG, Bakaletz AP, Mahan JD. Role of precipitating and nonprecipitating antibodies in glomerular immune complex formation. Kidney Int 1990 Jun; 37(6):1429-37.
    View PubMed
  115. Cosio FG, Mahan JD, Sedmak DD. Experimental glomerulonephritis induced by antigen that binds to glomerular fibronectin. Am J Kidney Dis 1990 Feb; 15(2):160-8.
    View PubMed
  116. Nahman NS Jr, Cosio FG. The effects of ciclosporin in experimental glomerulosclerosis. Nephron 1990; 56(4):414-20.
    View PubMed
  117. Cosio FG, Sedmak DD, Mahan JD, Nahman NS Jr. Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 1989 Jul; 36(1):100-7.
    View PubMed
  118. Birmingham DJ, Cosio FG. Characterization of the baboon erythrocyte C3b-binding protein. J Immunol 1989 May 1; 142(9):3140-4.
    View PubMed
  119. Dorval BL, Cosio FG, Birmingham DJ, Hebert LA. Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J Immunol 1989 Apr 15; 142(8):2721-7.
    View PubMed
  120. Nahman NS Jr, Cosio FG, Mahan JD, Henry ML, Ferguson RM. Cyclosporine nephrotoxicity in spontaneously hypertensive rats. Transplantation 1988 Apr; 45(4):768-72.
    View PubMed
  121. Cosio FG, Bakaletz AP. Role of fibronectin on the clearance and tissue uptake of antigen and immune complexes in rats. J Clin Invest 1987 Nov; 80(5):1270-9.
    View PubMed
  122. Cosio FG, Innes JT, Nahman NS Jr, Mahan JD, Ferguson RM. Combined nephrotoxic effects of cyclosporine and endotoxin. Transplantation 1987 Sep; 44(3):425-8.
    View PubMed
  123. Cosio FG, Birmingham DJ, Sexton DJ, Hebert LA. Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol 1987 Apr 15; 138(8):2587-92.
    View PubMed
  124. Nahman NS Jr, Cosio FG, Kolkin S, Mendell JR, Sharma HM. Cyclosporine nephrotoxicity without major organ transplantation. Ann Intern Med 1987 Mar; 106(3):400-2.
    View PubMed
  125. Cosio FG, Hebert LA, Birmingham DJ, Dorval BL, Bakaletz AP, Kujala GA, Edberg JC, Taylor RP. Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clinical Immunology & Immunopathology 1987 Jan; 42(1):1-9.
    View PubMed
  126. Cosio FG, Bakaletz AP. Binding of human fibronectin to antigen-antibody complexes. Journal of Laboratory & Clinical Medicine 1986 May; 107(5):453-8.
    View PubMed
  127. Waxman FJ, Hebert LA, Cosio FG, Smead WL, VanAman ME, Taguiam JM, Birmingham DJ. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest 1986 Jan; 77(1):82-9.
    View PubMed
  128. Cosio FG, Harker C, Batard MA, Brandt JT, Griffin JH. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. Journal of Laboratory & Clinical Medicine 1985 Aug; 106(2):218-22.
    View PubMed
  129. Cosio FG, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementemia. Lancet 1985 Jul 20; 2(8447):118-21.
    View PubMed
  130. Cosio FG, Eddy A, Mentser MI, Bergstein JM. Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome. Am J Med 1985 Apr; 78(4):549-54.
    View PubMed
  131. Cosio FG, Bakaletz AP. Abnormal plasma fibronectin levels in patients with proteinuria. Journal of Laboratory & Clinical Medicine 1984 Dec; 104(6):867-72.
    View PubMed
  132. Eddy A, Newman SL, Cosio F, LeBien T, Michael A. The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody. Clinical Immunology & Immunopathology 1984 Jun; 31(3):371-89.
    View PubMed
  133. Cosio FG. Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes. Journal of Laboratory & Clinical Medicine 1984 Apr; 103(4):613-9.
    View PubMed
  134. Genin C, Cosio F, Michael AF. Macromolecular charge and reticuloendothelial function: comparison between the kinetics of administered native and cationized ferritins and the corresponding immune complexes in the mouse. Immunology 1984 Feb; 51(2):225-38.
    View PubMed
  135. Cosio FG, Hoidal JR, Douglas SD, Michael AF. Binding of soluble immune complexes by human monocytes and pulmonary macrophages: effects of cigarette smoking. Journal of Laboratory & Clinical Medicine 1982 Sep; 100(3):469-76.
    View PubMed
  136. Cosio FG, Douglas SD, Michael AF. The human FcR. III. Effects of pronase on soluble immune complex binding by polymorphonuclear leucocytes, monocytes and pulmonary macrophages. Immunology 1982 Jun; 46(2):395-400.
    View PubMed
  137. Cosio FG, Lam S, Folami AO, Conley ME, Michael AF. Immune regulation of immunoglobulin production in IgA-nephropathy. Clinical Immunology & Immunopathology 1982 May; 23(2):430-6.
    View PubMed
  138. Cosio FG, Ackerman SK, Douglas SD, Friend PS, Michael AF. Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology 1981 Dec; 44(4):773-80.
    View PubMed
  139. Cosio FG, Giebink GS, Le CT, Schiffman G. Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int 1981 Aug; 20(2):254-8.
    View PubMed
  140. Cosio FG, Pence TV, Shapiro FL, Kjellstrand CM. Severe renal failure in multiple myeloma. Clin Nephrol 1981 Apr; 15(4):206-10.
    View PubMed
  141. Giebink GS, Le CT, Cosio FG, Spika JS, Schiffman G. Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae. Rev Infect Dis 1981 Mar-Apr; 3 Suppl:S168-78.
    View PubMed
  142. Kjellstrand CM, Matas A, Cosio FG, Davin T. Are malignancies increased in uremia and dialysis? Proc Int Congress Neph 1981; 1217-22.
  143. Cosio FG, Amer H, Grande JP, Larson TS, Stegall MD, Griffin MD. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation 2007 Feb 27; 83(4):411-6.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.